Sanofi

www.sanofi.com

54 Rue La Boetie
Paris
75008
France

+33 1 53 77 40 00

Activities

Manufacturing | Ingredients | Research & Development | Pharmaceutical | Dietary supplements | Active Nutrition | Food | Nutraceutical

Brands

Anthisan; Brochlor; Brolene; Dioralyte; Nasacort; Opticrom;

Related Companies

Related Content

Sanofi's ALTUVIIIO approved by the US FDA
Sanofi's ALTUVIIIO approved by the US FDA
Sanofi increases evergreen fund to $750m
Sanofi increases evergreen fund to $750m
Innate Pharma and Sanofi launch NK cell engager programme
Innate Pharma and Sanofi launch NK cell engager programme
Sanofi and GSK’s COVID-19 booster vaccine approved by the European Commission
Sanofi and GSK’s COVID-19 booster vaccine approved by the European Commission
Therapeutic: efanesoctocog alfa for haemophilia A
Therapeutic: efanesoctocog alfa for haemophilia A
Neuraxpharm to increase branded business by acquiring established Sanofi products
Neuraxpharm to increase branded business by acquiring established Sanofi products
C4XD receives first milestone payment of €3 million from Sanofi
C4XD receives first milestone payment of €3 million from Sanofi
Pfizer joins drug target identification consortium
Pfizer joins drug target identification consortium
Sanofi reveals updated corporate brand and logo
Sanofi reveals updated corporate brand and logo
Exscientia and Sanofi establish AI-based research collaboration
Exscientia and Sanofi establish AI-based research collaboration
Sanofi and GSK announce positive preliminary COVID booster data
Sanofi and GSK announce positive preliminary COVID booster data
Sanofi to acquire Origimm Biotechnology
Sanofi to acquire Origimm Biotechnology
Sanofi and GSK COVID-19 vaccine shows promising Phase II results
Sanofi and GSK COVID-19 vaccine shows promising Phase II results
Sanofi acquires mRNA specialist Tidal Therapeutics
Sanofi acquires mRNA specialist Tidal Therapeutics
Sanofi invests in influenza vaccine facility in Canada
Sanofi invests in influenza vaccine facility in Canada